Results 281 to 290 of about 512,940 (405)

Molecular Determinants of Receptor Affinity and Selectivity of the Natural Δ-Opioid Agonist, Dermenkephalin

open access: hybrid, 1989
Sandrine Sagan   +5 more
openalex   +1 more source

An Economic Perspective on Sampling in Dermatology

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Medication samples are defined by the United States Code of Federal Regulations as small quantities of prescription drugs intended to promote the sale of medications and not permitted to be sold. Objectives The use of samples is controversial, particularly in dermatology.
Max Oscherwitz   +4 more
wiley   +1 more source

Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework.

open access: yesJournal of Analytical Toxicology, 2016
Amanda L A Mohr   +5 more
semanticscholar   +1 more source

Integrating Harm Reduction and Trauma‐Informed Care in Undergraduate Dental Education

open access: yes
Journal of Dental Education, EarlyView.
Malak Abuhatem   +3 more
wiley   +1 more source

A Retrospective Analysis Into the Effect of Punch Grafts in Patients With Chronic Ulcers of the Lower Leg

open access: yesJEADV Clinical Practice, EarlyView.
Punch grafting was retrospectively evaluated in patients with chronic lower leg ulcers treated at Erasmus MC between 2018 and 2023. Median pain scores significantly decreased after 6 weeks. Opioid use declined and 30% of patients no longer required analgesics. Complete wound closure was achieved in 7% of cases.
M. van Zanten   +4 more
wiley   +1 more source

Guideline for Prescribing Opioids for Chronic Pain

open access: yesJournal of Pain & Palliative Care Pharmacotherapy, 2016
Centers for Disease Control and Prevention, Public
semanticscholar   +1 more source

Postcommercialisation outcomes of bridge‐enhanced anterior cruciate ligament restoration: The first 100 Bridge registry patients

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
ABSTRACT Purpose To review adverse events and outcomes at least 1 year postoperatively from Bridge enhanced ACL restoration (BEAR) in the first 100 subjects of the Bridge registry, a postcommercialisation prospective cohort. Methods Consecutive BEAR patients were invited to enroll in the Bridge registry.
Jocelyn Wittstein   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy